Clinical Trial Update: Exogenous Ketone Esters for Refractory Status Epileptics [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update shows ongoing recruitment for a Phase 2/3 study evaluating exogenous ketone esters to treat refractory status epilepticus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Exogenous ketone esters (ketone ester)

Snippet

Sponsor: Sohag University | Conditions: Status Epilepticus | Phase 2, Phase 3 | Status: RECRUITING